Tate & Lyle | TATE - Cash And Equivalent

Stock Price
349.60
Daily Change
-0.40 -0.11%
Monthly
-2.56%
Yearly
-36.78%
Q2 Forecast
344.12

Tate & Lyle reported GBP475M in Cash and Equivalent for its fiscal semester ending in June of 2023.





Cash And Equivalent Change Date
Agrana Beteiligungs EUR 88.9M 29.44M Sep/2025
Anglo-eastern Plants USD 244.7M 62.79M Jun/2025
Associated British Foods GBP 1.06B 299M Jun/2025
Austevoll Seafood NOK 5.1B 411M Dec/2025
Beiersdorf EUR 1.2B 33M Dec/2025
British American Tobacco GBP 4.4B 1.53B Jun/2025
Danone EUR 1.98B 364M Dec/2025
Diageo GBP 2.2B 544M Jun/2025
Givaudan CHF 603M 3M Jun/2024
Glanbia EUR 417M 116.1M Jan/2025
Imperial Brands GBP 1.85B 1.26B Dec/2022
International Flavors Fragrances USD 590M 31M Dec/2025
L'Oréal EUR 9.86B 5.04B Dec/2025
Nestle CHF 4.58B 73M Dec/2025
Nomad Foods EUR 193.6M 73M Sep/2025
Ontex EUR 96.7M 39.8M Jun/2025
Pernod Ricard EUR 2.4B 569M Dec/2025
Premier Foods GBP 64.4M 10.1M Dec/2023
Primary Health Properties ZAR 11.5M 8M Jun/2025
Reckitt Benckiser GBP 880M 106M Dec/2024
Tate & Lyle GBP 475M 41M Jun/2023
Unilever EUR 4.34B 1.79B Jun/2025